Implementation of supervised physical training to reduce vasovagal syncope recurrence: A randomized controlled trial.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
08 2022
Historique:
revised: 06 04 2022
received: 05 11 2021
accepted: 01 05 2022
pubmed: 1 6 2022
medline: 24 8 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Physical techniques used for the prevention of vasovagal syncope have limited evidence for efficacy. We aimed to evaluate multimodal supervised physical training as a treatment approach. In this 1:1 randomized trial, patients with ≥2 episodes of clinically diagnosed vasovagal syncope were included. On top of standard care, the intervention arm performed supervised tilt training and aerobic exercise in six sessions at a cardiac rehabilitation center (three sessions during the first month, and then at 3-month intervals), plus home tilt training. The control arm received standard care with a similar protocol of home tilt training. The primary outcome was time to first syncopal recurrence during 1 year of follow-up. Fifty participants were randomized (mean age: 34.5 ± 14.8 years; 64% female). The rate of syncopal recurrence was 28% and 64% within the intervention and control arms, respectively, with significantly higher syncope-free survival at 1 year in the intervention arm (Log-rank p = .003). The frequency of recurrent syncopal events was significantly lower with physical training (p = .017). Participants in the intervention arm reported significantly higher adherence to the home tilt training program (80% vs. 52%; p = .037). Among patients with recurrent vasovagal syncope, a supervised program of tilt training and aerobic exercise reduced syncopal recurrence. Future trials are warranted to further investigate multimodal supervised physical techniques as a therapeutic approach in treating vasovagal syncope.

Identifiants

pubmed: 35634869
doi: 10.1111/jce.15578
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1863-1870

Subventions

Organisme : Tehran University of Medical Sciences and Health Services
ID : 98-3-101-43569

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Colman N, Nahm K, Ganzeboom KS, et al. Epidemiology of reflex syncope. Clin Auton Res. 2004;14(suppl 1):9-17.
Ganzeboom KS, Mairuhu G, Reitsma JB, Linzer M, Wieling W, van Dijk N. Lifetime cumulative incidence of syncope in the general population: a study of 549 Dutch subjects aged 35-60 years. J Cardiovasc Electrophysiol. 2006;17(11):1172-1176.
Brignole M, Menozzi C, Bartoletti A, et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J. 2006;27(1):76-82.
Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med. 2002;347(12):878-885.
Ng J, Sheldon RS, Ritchie D, Raj V, Raj SR. Reduced quality of life and greater psychological distress in vasovagal syncope patients compared to healthy individuals. Pacing Clin Electrophysiol. 2019;42(2):180-188.
Jorge JG, Raj SR, Teixeira PS, Teixeira JA, Sheldon RS. Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. Europace. 2021;23(7):1092-1099.
Sun BC. Quality-of-life, health service use, and costs associated with syncope. Prog Cardiovasc Dis. 2013;55(4):370-375.
Sahota IS, Maxey C, Pournazari P, Sheldon RS. Clusters, gaps, and randomness: vasovagal syncope recurrence patterns. JACC Clin Electrophysiol. 2017;3(9):1046-1053.
Sheldon R, Faris P, Tang A, et al. Midodrine for the prevention of vasovagal syncope. Ann Intern Med. 2021;174:1349-1356.
Raj SR, Coffin ST. Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hypotension. Prog Cardiovasc Dis. 2013;55(4):425-433.
van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope. The physical counterpressure manoeuvres trial (PC-trial). J Am Coll Cardiol. 2006;48(8):1652-1657.
Brignole M, Moya A, de Lange FJ, et al. ESC guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883-1948.
Duygu H, Zoghi M, Turk U, et al. The role of tilt training in preventing recurrent syncope in patients with vasovagal syncope: a prospective and randomized study. Pacing Clin Electrophysiol. 2008;31(5):592-596.
Zeng H, Ge K, Zhang W, Wang G, Guo L. The effect of orthostatic training in the prevention of vasovagal syncope and its influencing factors. Int Heart J. 2008;49(6):707-712.
Gardenghi G, Rondon MU, Braga AM, et al. The effects of exercise training on arterial baroreflex sensitivity in neurally mediated syncope patients. Eur Heart J. 2007;28(22):2749-2755.
Takahagi VCM, Costa DC, Crescêncio JC, Gallo Junior L. Physical training as non-pharmacological treatment of neurocardiogenic syncope. Arq Bras Cardiol. 2014;102(3):288-294.
Tan MP, Newton JL, Chadwick TJ, Gray JC, Nath S, Parry SW. Home orthostatic training in vasovagal syncope modifies autonomic tone: results of a randomized, placebo-controlled pilot study. Europace. 2010;12(2):240-246.
Sadeghian S, Aminorroaya A, Tajdini M. The syncope unit of Tehran Heart Center. Eur Heart J. 2021;42(2):148-150.
Raj SR, Sheldon RS. Vasovagal syncope needs the “expert touch”. JACC Clin Electrophysiol. 2022;8(2):150-151.
Pournazari P, Sahota I, Sheldon R. High remission rates in vasovagal syncope: systematic review and meta-analysis of observational and randomized studies. JACC Clin Electrophysiol. 2017;3(4):384-392.
Sud S, Massel D, Klein GJ, et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med. 2007;120(1):54-62.
Ng J, Sheldon RS, Maxey C, et al. Quality of life improves in vasovagal syncope patients after clinical trial enrollment regardless of fainting in follow-up. Auton Neurosci Basic Clin. 2019;219:42-48.
Sahota I, Sheldon R, Pournazari P. Clinical improvement of vasovagal syncope in the absence of specific therapies: the Seinfeld effect. Cardiol J. 2014;21(6):637-642.
Sharma G, Ramakumar V, Sharique M, et al. Effect of yoga on clinical outcomes and quality of life in patients with vasovagal syncope (LIVE-yoga). JACC Clin Electrophysiol. 2022;8(2):141-149.
Shenthar J, Gangwar RS, Banavalikar B, Benditt DG, Lakkireddy D, Padmanabhan D. A randomized study of yoga therapy for the prevention of recurrent reflex vasovagal syncope. Europace. 2021;23(9):1479-1486.
Jardine DL, Wieling W, Brignole M, Lenders JWM, Sutton R, Stewart J. The pathophysiology of the vasovagal response. Hear Rhythm. 2018;15(6):921-929.
Wieling W, Jardine DL, De Lange FJ, et al. Cardiac output and vasodilation in the vasovagal response: an analysis of the classic papers. Hear Rhythm. 2016;13(3):798-805.
Thomson HL, Wright K, Frenneaux M. Baroreflex sensitivity in patients with vasovagal syncope. Circulation. 1997;95(2):395-400.
van Dijk JG, Wieling W. Pathophysiological basis of syncope and neurological conditions that mimic syncope. Prog Cardiovasc Dis. 2013;55(4):345-356.
Wieling W, Colman N, Krediet CTP, Freeman R. Nonpharmacological treatment of reflex syncope. Clin Auton Res. 2004;14(suppl 1):i62-i70.
Foglia-Manzillo G, Giada F, Gaggioli G, et al. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study. Europace. 2004;6(3):199-204.
On YK, Park J, Huh J, Soo Kim J. Is home orthostatic self-training effective in preventing neurally mediated syncope? Pacing Clin Electrophysiol. 2007;30(5):638-643.
Gurevitz O, Barsheshet A, Bar-Lev D, et al. Tilt training: does it have a role in preventing vasovagal syncope? Pacing Clin Electrophysiol. 2007;30(12):1499-1505.
Laranjo S, Martins Oliveira M, Tavares C, et al. Tilt training increases vasoconstrictor reserve in patients with neurocardiogenic syncope. Rev Port Cardiol. 2012;31(7-8):469-476.

Auteurs

Faezeh Aghajani (F)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Hamed Tavolinejad (H)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Saeed Sadeghian (S)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ali Bozorgi (A)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Arash Jalali (A)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Ali Vasheghani-Farahani (A)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Somayeh Yadangi (S)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Sepideh Niazi (S)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Amirhossein Poopak (A)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Masih Tajdini (M)

Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH